JP2021500864A5 - - Google Patents

Info

Publication number

JP2021500864A5

JP2021500864A5 JP2020517500A JP2020517500A JP2021500864A5 JP 2021500864 A5 JP2021500864 A5 JP 2021500864A5 JP 2020517500 A JP2020517500 A JP 2020517500A JP 2020517500 A JP2020517500 A JP 2020517500A JP 2021500864 A5 JP2021500864 A5 JP 2021500864A5

Authority

JP

Japan

Prior art keywords

composition

seq

guide

ttr

subject

Prior art date

2018-09-28

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims 52
• 238000000034 method Methods 0.000 claims 27
• 125000003729 nucleotide group Chemical group 0.000 claims 24
• 108020005004 Guide RNA Proteins 0.000 claims 21
• 239000002773 nucleotide Substances 0.000 claims 19
• 101150091380 TTR gene Proteins 0.000 claims 11
• 239000011230 binding agent Substances 0.000 claims 10
• 230000035772 mutation Effects 0.000 claims 9
• 230000004568 DNA-binding Effects 0.000 claims 8
• 238000012986 modification Methods 0.000 claims 7
• 230000004048 modification Effects 0.000 claims 7
• 230000005782 double-strand break Effects 0.000 claims 6
• 108091027544 Subgenomic mRNA Proteins 0.000 claims 5
• 150000002632 lipids Chemical class 0.000 claims 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
• 102000001049 Amyloid Human genes 0.000 claims 4
• 108010094108 Amyloid Proteins 0.000 claims 4
• 230000027455 binding Effects 0.000 claims 4
• 210000004027 cell Anatomy 0.000 claims 4
• 210000002966 serum Anatomy 0.000 claims 4
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims 4
• 210000003494 hepatocyte Anatomy 0.000 claims 3
• 108020004707 nucleic acids Proteins 0.000 claims 3
• 102000039446 nucleic acids Human genes 0.000 claims 3
• 150000007523 nucleic acids Chemical class 0.000 claims 3
• 239000008194 pharmaceutical composition Substances 0.000 claims 3
• 108020004414 DNA Proteins 0.000 claims 2
• 206010060860 Neurological symptom Diseases 0.000 claims 2
• 238000009825 accumulation Methods 0.000 claims 2
• 206010002022 amyloidosis Diseases 0.000 claims 2
• 230000000747 cardiac effect Effects 0.000 claims 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
• 230000000295 complement effect Effects 0.000 claims 2
• 230000037430 deletion Effects 0.000 claims 2
• 238000012217 deletion Methods 0.000 claims 2
• 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 claims 2
• 230000009977 dual effect Effects 0.000 claims 2
• 230000037431 insertion Effects 0.000 claims 2
• 238000003780 insertion Methods 0.000 claims 2
• 239000002105 nanoparticle Substances 0.000 claims 2
• 230000002265 prevention Effects 0.000 claims 2
• 208000024891 symptom Diseases 0.000 claims 2
• NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims 1
• 102220470698 BUD13 homolog_V30P_mutation Human genes 0.000 claims 1
• 108091033409 CRISPR Proteins 0.000 claims 1
• 206010007509 Cardiac amyloidosis Diseases 0.000 claims 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 claims 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 claims 1
• 208000034846 Familial Amyloid Neuropathies Diseases 0.000 claims 1
• 206010019889 Hereditary neuropathic amyloidosis Diseases 0.000 claims 1
• 108020004485 Nonsense Codon Proteins 0.000 claims 1
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
• 102220558130 Olfactory receptor 2A1/2A42_V30L_mutation Human genes 0.000 claims 1
• 108700026244 Open Reading Frames Proteins 0.000 claims 1
• 230000003941 amyloidogenesis Effects 0.000 claims 1
• 235000012000 cholesterol Nutrition 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 230000037433 frameshift Effects 0.000 claims 1
• 230000002496 gastric effect Effects 0.000 claims 1
• 230000006698 induction Effects 0.000 claims 1
• 230000001939 inductive effect Effects 0.000 claims 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims 1
• 210000004185 liver Anatomy 0.000 claims 1
• 108020004999 messenger RNA Proteins 0.000 claims 1
• 210000005036 nerve Anatomy 0.000 claims 1
• 230000037434 nonsense mutation Effects 0.000 claims 1
• 230000001575 pathological effect Effects 0.000 claims 1
• 239000000546 pharmaceutical excipient Substances 0.000 claims 1
• 102200150628 rs151220873 Human genes 0.000 claims 1
• 102200017272 rs28931576 Human genes 0.000 claims 1
• 102220128569 rs777178486 Human genes 0.000 claims 1
• 201000007905 transthyretin amyloidosis Diseases 0.000 claims 1
• 150000003626 triacylglycerols Chemical class 0.000 claims 1
• 239000013598 vector Substances 0.000 claims 1
• 239000013603 viral vector Substances 0.000 claims 1